Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials

Journal of Heart and Lung Transplantation

Volumn 30, Issue 9, 2011, Pages 982-989

  Benza, Raymond L ^a   Gomberg Maitland, Mardi ^b   Naeije, Robert ^c   Arneson, Carl P ^d   Lang, Irene M ^e  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c ERASME HOSPITAL   (Belgium)

^d UNITED THERAPEUTICS CORPORATION   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

6MWD; medical therapy; prostacyclin; survival

Indexed keywords

PLACEBO; UNIPROST;

ADOLESCENT; ADULT; AGED; CHILD; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HUMAN; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SURVIVAL; TREATMENT DURATION; WALKING;

EID: 80051471867     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2011.03.011     Document Type: Article

References (30)

1. V.V. McLaughlin, S.L. Archer, and D.B. Badesch ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc; and the Pulmonary Hypertension Association J Am Coll Cardiol 53 2009 1573 1619
2. G.E. D'Alonzo, R.J. Barst, and S.M. Ayres Survival in patients with primary pulmonary hypertension: results from a national prospective registry Ann Intern Med 115 1991 343 349
3. R.J. Barst, L.J. Rubin, and W.A. Long A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension N Engl J Med 334 1996 296 301 (Pubitemid 26033085)
4. N. Gali, H. Olschewski, and R.J. Oudiz Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2 Circulation 117 2008 3010 3019
5. N. Gali, H.A. Ghofrani, and A. Torbicki Sildenafil citrate therapy for pulmonary arterial hypertension N Engl J Med 353 2005 2148 2157 (Pubitemid 41653106)
6. L.J. Rubin, D.B. Badesch, and R.J. Barst Bosentan therapy for pulmonary arterial hypertension N Engl J Med 346 2002 896 903 (Pubitemid 34984638)
7. G. Simonneau, R.J. Barst, and N. Galie Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial Am J Respir Crit Care Med 165 2002 800 804 (Pubitemid 34229650)
8. O. Sitbon, M. Humbert, and H. Nunes Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival J Am Coll Cardiol 40 2002 780 788 (Pubitemid 34925627)
9. V.F. Tapson, M. Gomberg-Maitland, and V.V. McLaughlin Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial Chest 129 2006 683 688
10. V.V. McLaughlin, R.L. Benza, and L.J. Rubin Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial J Am Coll Cardiol 55 2010 1915 1922
11. N. Gali, B.H. Brundage, and H.A. Ghofrani Tadalafil therapy for pulmonary arterial hypertension Circulation 119 2009 2894 2903
12. N. Gali, A. Manes, and L. Negro A meta-analysis of randomized controlled trials in pulmonary arterial hypertension Eur Heart J 30 2009 394 403
13. S.D. Halpern, R. Doyle, and S.M. Kawut The ethics of randomized clinical trials in pulmonary arterial hypertension Proc Am Thorac Soc 5 2008 631 635 (Pubitemid 352031536)
14. H.A. Ghofrani, M.W. Wilkins, and S. Rich Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension Circulation 118 2008 1195 1201
15. T. Thenappan, S.J. Shah, and S. Rich Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation Eur Respir J 35 2010 1079 1087
16. V.V. McLaughlin, A. Shillington, and S. Rich Survival in primary pulmonary hypertension: the impact of epoprostenol therapy Circulation 106 2002 1477 1482
17. S. Miyamoto, N. Nagaya, and T. Satoh Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: comparison with cardiopulmonary exercise testing Am J Respir Crit Care Med 161 2000 487 492 (Pubitemid 30129457)
18. G. Paciocco, F.J. Martinez, and E. Bossone Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension Eur Respir J 17 2001 647 652 (Pubitemid 32492552)
19. R.L. Benza, D.P. Miller, and M. Gomberg-Maitland Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) Circulation 122 2010 164 172
20. M. Humbert, O. Sitbon, and A. Chaouat Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era Circulation 122 2010 156 163
21. R.J. Barst, N. Galie, and R. Naeije Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil Eur Respir J 28 2006 1195 1203 (Pubitemid 44883856)
22. V.V. McLaughlin, S.P. Gaine, and R.J. Barst Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension J Cardiovasc Pharmacol 41 2003 293 299 (Pubitemid 36135255)
23. M.H. Park, and L.J. Rubin The globalization of clinical trials in pulmonary arterial hypertension J Heart Lung Transplant 29 2010 157 158
24. M.T. Kearney, K.A.A. Fox, and A.J. Lee Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure J Am Coll Cardiol 40 2002 1801 1808 (Pubitemid 35341959)
25. S.J. Shah, T. Thenappan, and S. Rich Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension Circulation 117 2008 2475 2483 (Pubitemid 351670454)
26. B. Sztrymf, R. Souza, and L. Bertoletti Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension Eur Respir J 35 2010 1286 1293
27. S. Rich The current treatment of pulmonary arterial hypertension: time to redefine success Chest 130 2006 1198 1202 (Pubitemid 44583753)
28. K. Roberts, I. Preston, and N.S. Hill Pulmonary hypertension trials: current end points are flawed, but what are the alternatives? Chest 130 2006 934 936 (Pubitemid 44583715)
29. I. Lang, M. Gomez-Sanchez, and M. Kneussl Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension Chest 129 2006 1636 1643 (Pubitemid 43894997)
30. J. Hiremath, S. Thanikachalam, and K. Parikh Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial J Heart Lung Transplant 29 2010 137 149